头颈部透明细胞癌(HCCC): 87例预后病理特征及分级方案的多中心回顾性研究

IF 7.1 1区 医学 Q1 PATHOLOGY
Bin Xu, Kartik Viswanathan, Marie Barbesier, Alexander Ladenheim, Cristina R Antonescu, Ronald Ghossein, Dan Lubin, Kelly Magliocca, Sayed Matar, Michael W Mikula, Isabella Tondi Resta, Dibisha Roy, Soo Yeon Sohn, Anuj Verma, Manju L Prasad, Lisa Rooper, Margaret Brandwein-Weber, Zubair Baloch, Nora Katabi
{"title":"头颈部透明细胞癌(HCCC): 87例预后病理特征及分级方案的多中心回顾性研究","authors":"Bin Xu, Kartik Viswanathan, Marie Barbesier, Alexander Ladenheim, Cristina R Antonescu, Ronald Ghossein, Dan Lubin, Kelly Magliocca, Sayed Matar, Michael W Mikula, Isabella Tondi Resta, Dibisha Roy, Soo Yeon Sohn, Anuj Verma, Manju L Prasad, Lisa Rooper, Margaret Brandwein-Weber, Zubair Baloch, Nora Katabi","doi":"10.1016/j.modpat.2025.100834","DOIUrl":null,"url":null,"abstract":"<p><p>Hyalinizing clear cell carcinoma (HCCC) is a salivary gland carcinoma characterized by the presence of clear and eosinophilic cells within a hyalinized stroma and the EWSR1 rearrangement. Aiming to identify prognostic factors and establish a grading system, we herein conducted a detailed clinicopathology review of a large retrospective cohort of 87 HCCCs from seven tertiary centers. Most HCCCs (91%) originated from minor salivary glands, although major salivary glands were affected in 8%. The most common sites were base of tongue, palate, nasopharynx, and maxilla . Eosinophilic cells were more prevalent than clear cells. Histologic features included Intraosseous component (19%), perineural invasion (48%), lymphovascular invasion (LVI, 16%), nuclear pleomorphism (14%), tumor necrosis (26%), and a mitotic index (MI) ≥5/2 mm<sup>2</sup>, 9%). Factors associated with increased risk of nodal metastasis at presentation included LVI, high MI, and tumor necrosis. The 10-year disease-specific survival (DSS), disease-free survival (DFS), and distant metastasis-free survival (DMFS) were 80%, 51%, and 87%, respectively. Significant prognostic factors identified on univariate survival analysis included MI≥5/2 mm<sup>2</sup>, tumor necrosis, atypical mitosis, and nuclear pleomorphism for DSS; LVI, MI≥5/2 mm<sup>2</sup>, and percentage of clear cells for DFS; and nodal metastasis, LVI, MI≥5/2 mm<sup>2</sup>, tumor necrosis, and atypical mitosis for DMFS. The only independent prognostic factor for DFS identified on multivariate survival analysis was MI≥5/2 mm<sup>2</sup>. High grade HCCCs, defined as tumors with MI≥5/2 mm<sup>2</sup> and/or tumor necrosis, were associated with increased risk of nodal metastasis at presentation and shortened DSS and DMFS. Among 67 HCCCs examined for EWSR1 rearrangement, 65 (97%) harbored EWSR1 translocation. In conclusion, we identified multiple prognostic factors in HCCC, including MI, necrosis, atypical mitosis, nuclear pleomorphism, lymphovascular invasion, and percentage of clear cells. We herein proposed a prognostically relevant two-tiered grading system, classifying HCCC with a MI≥5/10 2 mm<sup>2</sup> and/or tumor necrosis as high grade.</p>","PeriodicalId":18706,"journal":{"name":"Modern Pathology","volume":" ","pages":"100834"},"PeriodicalIF":7.1000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hyalinizing Clear Cell Carcinoma (HCCC) of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading scheme.\",\"authors\":\"Bin Xu, Kartik Viswanathan, Marie Barbesier, Alexander Ladenheim, Cristina R Antonescu, Ronald Ghossein, Dan Lubin, Kelly Magliocca, Sayed Matar, Michael W Mikula, Isabella Tondi Resta, Dibisha Roy, Soo Yeon Sohn, Anuj Verma, Manju L Prasad, Lisa Rooper, Margaret Brandwein-Weber, Zubair Baloch, Nora Katabi\",\"doi\":\"10.1016/j.modpat.2025.100834\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hyalinizing clear cell carcinoma (HCCC) is a salivary gland carcinoma characterized by the presence of clear and eosinophilic cells within a hyalinized stroma and the EWSR1 rearrangement. Aiming to identify prognostic factors and establish a grading system, we herein conducted a detailed clinicopathology review of a large retrospective cohort of 87 HCCCs from seven tertiary centers. Most HCCCs (91%) originated from minor salivary glands, although major salivary glands were affected in 8%. The most common sites were base of tongue, palate, nasopharynx, and maxilla . Eosinophilic cells were more prevalent than clear cells. Histologic features included Intraosseous component (19%), perineural invasion (48%), lymphovascular invasion (LVI, 16%), nuclear pleomorphism (14%), tumor necrosis (26%), and a mitotic index (MI) ≥5/2 mm<sup>2</sup>, 9%). Factors associated with increased risk of nodal metastasis at presentation included LVI, high MI, and tumor necrosis. The 10-year disease-specific survival (DSS), disease-free survival (DFS), and distant metastasis-free survival (DMFS) were 80%, 51%, and 87%, respectively. Significant prognostic factors identified on univariate survival analysis included MI≥5/2 mm<sup>2</sup>, tumor necrosis, atypical mitosis, and nuclear pleomorphism for DSS; LVI, MI≥5/2 mm<sup>2</sup>, and percentage of clear cells for DFS; and nodal metastasis, LVI, MI≥5/2 mm<sup>2</sup>, tumor necrosis, and atypical mitosis for DMFS. The only independent prognostic factor for DFS identified on multivariate survival analysis was MI≥5/2 mm<sup>2</sup>. High grade HCCCs, defined as tumors with MI≥5/2 mm<sup>2</sup> and/or tumor necrosis, were associated with increased risk of nodal metastasis at presentation and shortened DSS and DMFS. Among 67 HCCCs examined for EWSR1 rearrangement, 65 (97%) harbored EWSR1 translocation. In conclusion, we identified multiple prognostic factors in HCCC, including MI, necrosis, atypical mitosis, nuclear pleomorphism, lymphovascular invasion, and percentage of clear cells. We herein proposed a prognostically relevant two-tiered grading system, classifying HCCC with a MI≥5/10 2 mm<sup>2</sup> and/or tumor necrosis as high grade.</p>\",\"PeriodicalId\":18706,\"journal\":{\"name\":\"Modern Pathology\",\"volume\":\" \",\"pages\":\"100834\"},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.modpat.2025.100834\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.modpat.2025.100834","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

透明细胞癌(HCCC)是一种唾液腺癌,其特征是透明细胞和嗜酸性细胞存在于透明基质中,并且EWSR1重排。为了确定预后因素并建立分级系统,我们在此对来自7个三级中心的87例hcc进行了详细的临床病理回顾。大多数HCCCs(91%)起源于小唾液腺,尽管大唾液腺有8%受到影响。最常见的部位是舌根、上颚、鼻咽和上颌骨。嗜酸性细胞多于透明细胞。组织学特征包括骨内成分(19%),神经周围浸润(48%),淋巴血管浸润(LVI, 16%),核多形性(14%),肿瘤坏死(26%),有丝分裂指数(MI)≥5/2 mm2, 9%)。与淋巴结转移风险增加相关的因素包括LVI、高心肌梗死和肿瘤坏死。10年疾病特异性生存率(DSS)、无病生存率(DFS)和远端无转移生存率(DMFS)分别为80%、51%和87%。单因素生存分析确定的重要预后因素包括心肌梗死≥5/2 mm2、肿瘤坏死、非典型有丝分裂和DSS的核多形性;LVI、MI≥5/2 mm2、透明细胞百分比为DFS;淋巴结转移、LVI、MI≥5/ 2mm2、肿瘤坏死、非典型有丝分裂为DMFS。在多变量生存分析中确定的DFS的唯一独立预后因素是心肌梗死≥5/2 mm2。高级别hcc,定义为MI≥5/2 mm2和/或肿瘤坏死的肿瘤,与出现时淋巴结转移的风险增加、DSS和DMFS缩短相关。在检测EWSR1重排的67例hcc中,65例(97%)存在EWSR1易位。总之,我们确定了HCCC的多种预后因素,包括心肌梗死、坏死、非典型有丝分裂、核多形性、淋巴血管侵袭和透明细胞的百分比。我们在此提出了一个与预后相关的两级分级系统,将MI≥5/ 102mm2和/或肿瘤坏死的HCCC分类为高分级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hyalinizing Clear Cell Carcinoma (HCCC) of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading scheme.

Hyalinizing clear cell carcinoma (HCCC) is a salivary gland carcinoma characterized by the presence of clear and eosinophilic cells within a hyalinized stroma and the EWSR1 rearrangement. Aiming to identify prognostic factors and establish a grading system, we herein conducted a detailed clinicopathology review of a large retrospective cohort of 87 HCCCs from seven tertiary centers. Most HCCCs (91%) originated from minor salivary glands, although major salivary glands were affected in 8%. The most common sites were base of tongue, palate, nasopharynx, and maxilla . Eosinophilic cells were more prevalent than clear cells. Histologic features included Intraosseous component (19%), perineural invasion (48%), lymphovascular invasion (LVI, 16%), nuclear pleomorphism (14%), tumor necrosis (26%), and a mitotic index (MI) ≥5/2 mm2, 9%). Factors associated with increased risk of nodal metastasis at presentation included LVI, high MI, and tumor necrosis. The 10-year disease-specific survival (DSS), disease-free survival (DFS), and distant metastasis-free survival (DMFS) were 80%, 51%, and 87%, respectively. Significant prognostic factors identified on univariate survival analysis included MI≥5/2 mm2, tumor necrosis, atypical mitosis, and nuclear pleomorphism for DSS; LVI, MI≥5/2 mm2, and percentage of clear cells for DFS; and nodal metastasis, LVI, MI≥5/2 mm2, tumor necrosis, and atypical mitosis for DMFS. The only independent prognostic factor for DFS identified on multivariate survival analysis was MI≥5/2 mm2. High grade HCCCs, defined as tumors with MI≥5/2 mm2 and/or tumor necrosis, were associated with increased risk of nodal metastasis at presentation and shortened DSS and DMFS. Among 67 HCCCs examined for EWSR1 rearrangement, 65 (97%) harbored EWSR1 translocation. In conclusion, we identified multiple prognostic factors in HCCC, including MI, necrosis, atypical mitosis, nuclear pleomorphism, lymphovascular invasion, and percentage of clear cells. We herein proposed a prognostically relevant two-tiered grading system, classifying HCCC with a MI≥5/10 2 mm2 and/or tumor necrosis as high grade.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Modern Pathology
Modern Pathology 医学-病理学
CiteScore
14.30
自引率
2.70%
发文量
174
审稿时长
18 days
期刊介绍: Modern Pathology, an international journal under the ownership of The United States & Canadian Academy of Pathology (USCAP), serves as an authoritative platform for publishing top-tier clinical and translational research studies in pathology. Original manuscripts are the primary focus of Modern Pathology, complemented by impactful editorials, reviews, and practice guidelines covering all facets of precision diagnostics in human pathology. The journal's scope includes advancements in molecular diagnostics and genomic classifications of diseases, breakthroughs in immune-oncology, computational science, applied bioinformatics, and digital pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信